Pfizer’s CEO Buys Shares via Phantom Stock: Boosts Incentives & Signals Long‑Term Growth
Pfizer’s Form 4 shows CEO Albert Bourla’s phantom‑stock exercise, boosting his shares while keeping equity dilution low – a strategic move that underpins Pfizer’s commitment to long‑term growth and cutting‑edge therapeutics.
4 minutes to read
